Statistics for Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use
Total visits
| views | |
|---|---|
| Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use | 4 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 1 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| DOM-25-407.pdf | 61 |
| java.util.UUID:2bb29898-d3b4-4b6c-9de6-8d6dd5b69f08 | 38 |
| java.util.UUID:fda22b03-c0e8-423f-8c4b-3c0e05d48331 | 11 |
| java.util.UUID:f4ef29b2-c64f-40b7-bcec-1fa9977b6634 | 8 |
Top country views
| views | |
|---|---|
| United States | 3 |
| United Kingdom | 1 |
Top city views
| views | |
|---|---|
| Greenwood | 2 |
| Bournemouth | 1 |
| Indianapolis | 1 |